Redeye: Stille Q2 2023 - Solid progress
Redeye returns with an update on Stille following its Q2 2023 report. We have a largely positive take on the report, which slightly exceeded expectations in terms of sales and EBIT. We have moderately increased our base case.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/